References
- Pass HI, Mitchell JB, Johnson DH. Lung Cancer: Principles and Practice. Philadelphia: Lippincott Williams & Willkins, 2005:657-674.
- Burbige EJ, Radigan JJ, Belber JP. Metastatic lung carcinoma involving the gastrointestinal tract. Am J Gastroenterol 1980;74:504-506.
- Lau CP, Leung WK. Caecal metastasis from a primary small-cell lung carcinoma. Hong Kong Med J 2008;14: 152-153.
- Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-247. https://doi.org/10.1016/j.ejca.2008.10.026
- National Cancer Information Center. Cancer incidence [Internet]. Goyang: National Cancer Information Center, c2013 [cited 2013 Jan 25]. Available from: http://www. cancer.go.kr/ncic/cics_b/01/013/1268114_5873.html.
- Antler AS, Ough Y, Pitchumoni CS, Davidian M, Thelmo W. Gastrointestinal metastases from malignant tumors of the lung. Cancer 1982;49:170-172. https://doi.org/10.1002/1097-0142(19820101)49:1<170::AID-CNCR2820490134>3.0.CO;2-A
- Ryo H, Sakai H, Ikeda T, et al. Gastrointestinal metastasis from lung cancer. Nihon Kyobu Shikkan Gakkai Zasshi 1996;34:968-972.
- Yun IS, Lee JY, Lee JS, et al. Jejunal intussusception with gastrointestinal bleeding caused by metastatic lung cancer. Korean J Gastroenterol 2008;51:377-380.
- Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Eng J Med 2002;346: 85-91. https://doi.org/10.1056/NEJMoa003034
- Asakuma M, Yamamoto M, Wada M, et al. Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer. Cancer Chemother Pharmacol 2012;69:1529-1536. https://doi.org/10.1007/s00280-012-1858-2